BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35491081)

  • 1. Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
    Ponto J; Bell RB
    Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):315-324. PubMed ID: 35491081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Melanoma - A Review of Systemic Therapies.
    Lee KA; Nathan P
    Acta Derm Venereol; 2020 Jun; 100(11):adv00141. PubMed ID: 32346745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Considerations and Systemic Therapy of Melanoma.
    Gamboa AC; Lowe M; Yushak ML; Delman KA
    Surg Clin North Am; 2020 Feb; 100(1):141-159. PubMed ID: 31753109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and Neoadjuvant Therapeutics for the Treatment of Cutaneous Melanoma.
    Bruce WJ; Koljonen JL; Romanelli MR; Khan AU; Neumeister MW
    Clin Plast Surg; 2021 Oct; 48(4):651-658. PubMed ID: 34503725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant use of ipilimumab in locally advanced melanoma.
    Howie LJ; Tyler DS; Salama AK
    J Surg Oncol; 2015 Dec; 112(8):841-3. PubMed ID: 26768512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
    McKean MA; Amaria RN
    Am J Clin Dermatol; 2018 Oct; 19(5):639-646. PubMed ID: 30039289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations.
    Shalata W; Attal ZG; Solomon A; Shalata S; Abu Saleh O; Tourkey L; Abu Salamah F; Alatawneh I; Yakobson A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
    Pelster MS; Amaria RN
    Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant immunotherapy for melanoma.
    Thomas D; Bello DM
    J Surg Oncol; 2021 Mar; 123(3):789-797. PubMed ID: 33595889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.
    Czarnecka AM; Ostaszewski K; Błoński P; Szumera-Ciećkiewicz A; Kozak K; Placzke J; Borkowska A; Terlecka A; Rogala P; Świtaj T; Sałamacha M; Mitręga-Korab B; Krotewicz M; Dudzisz-Śledź M; Rutkowski P
    Eur J Surg Oncol; 2024 Jul; 50(7):108382. PubMed ID: 38763112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Managing cutaneous melanoma].
    Thomas L; Cochran AJ
    Cancer Radiother; 1998 Dec; 2(6):732-46. PubMed ID: 9922781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. News from the melanoma sessions of the European Cancer Congress 2017.
    Rutkowski P; Kozak K
    BMC Med; 2017 Mar; 15(1):57. PubMed ID: 28302128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy for malignant melanoma].
    Zaremba A; Zimmer L; Griewank KG; Ugurel S; Roesch A; Schadendorf D; Livingstone E
    Internist (Berl); 2020 Jul; 61(7):669-675. PubMed ID: 32462249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapies.
    Perez MC; Depalo DK; Zager JS
    Expert Opin Drug Saf; 2023; 22(9):789-797. PubMed ID: 37551723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives.
    Testori AAE; Ribero S; Indini A; Mandalà M
    Am J Clin Dermatol; 2019 Dec; 20(6):817-827. PubMed ID: 31177507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Non-melanoma Skin Cancer.
    Shalhout SZ; Emerick KS; Kaufman HL; Miller DM
    Curr Oncol Rep; 2021 Aug; 23(11):125. PubMed ID: 34448958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.
    Long GV; Menzies AM; Scolyer RA
    J Clin Oncol; 2023 Jun; 41(17):3236-3248. PubMed ID: 37104746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
    McKean MA; Amaria RN
    Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant and Neoadjuvant Treatment of Skin Cancer.
    Sacco AG; Daniels GA
    Facial Plast Surg Clin North Am; 2019 Feb; 27(1):139-150. PubMed ID: 30420067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.